The noncanonical NF-κB signaling pathway is an important branch of NF-κB signaling.It is involved in regulating multiple important biological processes,including inflammation and host immune response.A central adapt...The noncanonical NF-κB signaling pathway is an important branch of NF-κB signaling.It is involved in regulating multiple important biological processes,including inflammation and host immune response.A central adaptor protein of the noncanonical NF-κB pathway is NF-κB-inducing kinase(NIK),which activates the downstream kinase IKKαto process p100 to p52,thereby forming the RelB/p52 heterodimer to initiate the expression of target genes.Currently,many specific inhibitors and monoclonal antibodies targeting or triggering this pathway are being developed and tested for various diseases,including cancers,autoimmune diseases,and virus infection.Given that aberrant activation of the noncanonical NF-κB pathway is frequently observed in various liver diseases,targeting this pathway may be a promising therapeutic strategy to alleviate liver inflammation.Moreover,activation of this pathway may contribute to the antiviral immune response and promote the clearance of persistent hepatotropic virus infection.Here,we review the role of the noncanonical NF-κB pathway in the occurrence and development of different liver diseases,and discuss the potency and application of modulating the noncanonical NF-κB pathway for treatment of these liver diseases.展开更多
基金partly supported by grants from the National Natural Science Foundation of China(No.81871664)the National Science and Technology Major Project(No.2018ZX10301202-003).
文摘The noncanonical NF-κB signaling pathway is an important branch of NF-κB signaling.It is involved in regulating multiple important biological processes,including inflammation and host immune response.A central adaptor protein of the noncanonical NF-κB pathway is NF-κB-inducing kinase(NIK),which activates the downstream kinase IKKαto process p100 to p52,thereby forming the RelB/p52 heterodimer to initiate the expression of target genes.Currently,many specific inhibitors and monoclonal antibodies targeting or triggering this pathway are being developed and tested for various diseases,including cancers,autoimmune diseases,and virus infection.Given that aberrant activation of the noncanonical NF-κB pathway is frequently observed in various liver diseases,targeting this pathway may be a promising therapeutic strategy to alleviate liver inflammation.Moreover,activation of this pathway may contribute to the antiviral immune response and promote the clearance of persistent hepatotropic virus infection.Here,we review the role of the noncanonical NF-κB pathway in the occurrence and development of different liver diseases,and discuss the potency and application of modulating the noncanonical NF-κB pathway for treatment of these liver diseases.
